Pfizer has issued a recall for a high blood pressure medication distributed under three names. The recalled products were distributed from November 2019 to March 2022 throughout the United States and Puerto Rico.
The company said in a statement:
The recall covers Accuretic tablets, and two generic medications distributed by Greenstone: quinapril and hydrochlorothiazide and quinapril HCI/hydrochlorothiazide. In all, six lots of Accuretic tablets, one lot of quinapril and hydrochlorothiazide tablets and four lots of quinapril HCl/ hydrochlorothiazide tablets are included.
Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 10/12.5 mg Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 20/12.5 mg Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 20/25 mg quinapril and hydrochlorothiazide tablets, 20/25 mg quinapril HCl/hydrochlorothiazide tablets, 20/12.5 mg quinapril HCl/hydrochlorothiazide tablets, 20/25 mg
Click here for a full list from the Pfizer press release.
Nitrosamines may be unintentionally introduced when certain chemical reactions are used in the production of medications. These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time. Pfizer said it is not aware of any “adverse events” related to recall and there is “no immediate risk to patients taking the medications.”
High blood pressure is a growing problem. The number of people over 30 with the condition has doubled over the past 30 years, according to a 2021 study.
Patients currently taking the medication should consult with their healthcare provider about alternatives. If you believe you have the recalled products, call 1–888–843–0247 (Mon.-Fri. 7 a.m.-4 p.m. CT) for instructions on how to return the product and obtain reimbursement.